MedPath

FIBRALIGN CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)

Not Applicable
Recruiting
Conditions
Lymphedema
Edema
First Posted Date
2023-01-25
Last Posted Date
2025-03-11
Lead Sponsor
Fibralign Corporation
Target Recruit Count
60
Registration Number
NCT05695924
Locations
🇺🇸

Stanford University, Stanford, California, United States

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

Not Applicable
Recruiting
Conditions
Lymphedema
Edema
First Posted Date
2020-10-28
Last Posted Date
2025-03-11
Lead Sponsor
Fibralign Corporation
Target Recruit Count
60
Registration Number
NCT04606030
Locations
🇺🇸

The University of Chicago Biological Sciences Division/University of Chicago Medical Center, Chicago, Illinois, United States

🇺🇸

MD Anderson, Houston, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.